CORC  > 西安交通大学
Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report
Chen, Zhe-Ling; Zhao, Andi; Li, Pan; Zhang, Mi; Yang, Jiao; Zhang, Lingxiao; Zhao, Xiaoai; Yang, Jin; Wang, Le
刊名ONCOLOGY LETTERS
2018
卷号16页码:4614-4620
关键词gastric cancer human epidermal growth factor receptor 2-positive multi-line treatment trastuzumab
ISSN号1792-1074
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2913764
专题西安交通大学
推荐引用方式
GB/T 7714
Chen, Zhe-Ling,Zhao, Andi,Li, Pan,et al. Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report[J]. ONCOLOGY LETTERS,2018,16:4614-4620.
APA Chen, Zhe-Ling.,Zhao, Andi.,Li, Pan.,Zhang, Mi.,Yang, Jiao.,...&Wang, Le.(2018).Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report.ONCOLOGY LETTERS,16,4614-4620.
MLA Chen, Zhe-Ling,et al."Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report".ONCOLOGY LETTERS 16(2018):4614-4620.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace